GNL Gut and Liver
  1. Sherif Mogawer, Mona Mansour, Mohamed Marie, Mervat El-Ansary, Samah Abd El-Hamid. Insulin resistance: a predictor for response to interferon-based therapy in Egyptian patients with chronic HCV genotype 4. Comp Clin Pathol 2014;23:7
    https://doi.org/10.1007/s00580-012-1560-0
  2. Jing‑Hong Hu, Ming‑Ling Chang, Nai‑Jen Liu, Chu‑Ting Yeh, Tung‑Jung Huang. Effect of HCV treatment response on insulin resistance: A systematic review and meta‑analysis. Exp Ther Med 2019
    https://doi.org/10.3892/etm.2019.7995
  3. Cheng‐Hao Tseng, Yao‐Chun Hsu, Chi‐Yang Chang, Chih‐Wen Lin, Jaw‐Town Lin, Lein‐Ray Mo. Change in insulin resistance according to virological response during antiviral treatment for hepatitis C virus infection. Adv in Digestive Medicine 2016;3:43
    https://doi.org/10.1016/j.aidm.2014.12.003
  4. Amal A Mohamed, Samah A Loutfy, James D Craik, Abdel Gawad M Hashem, Ibrahem Siam. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma. Virol J 2011;8
    https://doi.org/10.1186/1743-422X-8-496
  5. Marc G. Ghany, T. Jake Liang. Hepatitis C Virus II. 2011.
    https://doi.org/10.1007/978-4-431-56101-9_1
  6. Pierre Deltenre, Alexandre Louvet, Maud Lemoine, Abbas Mourad, Laetitia Fartoux, Christophe Moreno, Jean Henrion, Philippe Mathurin, Lawrence Serfaty. Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: A meta-analysis. Journal of Hepatology 2011;55:1187
    https://doi.org/10.1016/j.jhep.2011.03.010
  7. Shilpa Lingala, Marc G. Ghany. Natural History of Hepatitis C. Gastroenterology Clinics of North America 2015;44:717
    https://doi.org/10.1016/j.gtc.2015.07.003
  8. A. A. Butt, T. Umbleja, J. W. Andersen, K. E. Sherman, R. T. Chung. Impact of Peginterferon Alpha and Ribavirin Treatment on Lipid Profiles and Insulin Resistance in Hepatitis C Virus/HIV-Coinfected Persons: The AIDS Clinical Trials Group A5178 Study. Clinical Infectious Diseases 2012;55:631
    https://doi.org/10.1093/cid/cis463
  9. Cheng-Hung Chien, Chih-Lang Lin, Ching-Chih Hu, Jia-Jang Chang, Rong-Nan Chien. Clearance of Hepatitis C Virus Improves Insulin Resistance During and After Peginterferon and Ribavirin Therapy. Journal of Interferon & Cytokine Research 2015;35:981
    https://doi.org/10.1089/jir.2014.0200
  10. Luigi E Adinolfi, Luciano Restivo, Rosa Zampino, Amedeo Lonardo, Paola Loria. Metabolic alterations and chronic hepatitis C: treatment strategies. Expert Opinion on Pharmacotherapy 2011;12:2215
    https://doi.org/10.1517/14656566.2011.597742
  11. Anne-Claire Desbois, Patrice Cacoub. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. WJG 2017;23:1697
    https://doi.org/10.3748/wjg.v23.i9.1697
  12. Shira Yair-Sabag, Elchanan Nussinson, Ofir Ben-Assuli, Fahmi Shibli, Azmi Shahbari, Shira Zelber-Sagi. Retrospective study of the associations between hepatitis C virus infection and metabolic factors. WJH 2016;8:1269
    https://doi.org/10.4254/wjh.v8.i30.1269
  13. C. H. Y. Chan, R. D. Hansen, R. S. Gilliver, B. E. Jones. Sustained virological response following chronic hepatitis C treatment is associated with improvement in insulin resistance. Internal Medicine Journal 2013;43:656
    https://doi.org/10.1111/imj.12136
  14. Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim. The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients. Clin Mol Hepatol 2014;20:38
    https://doi.org/10.3350/cmh.2014.20.1.38
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd